---
aliases:
- (Bergmann et al., 2020)
author: Bergmann, Melanie and Prieschl, Manuela and Stefani, Ambra and Heidbreder,
  Anna and Walser, Gerald and Frauscher, Birgit and Unterberger, Iris and Högl, Birgit
citekey: bergmann2020ProspectiveControlledStudy
date_added: '2025-03-23'
doi: 10.1016/j.sleep.2020.09.001
journal: Sleep Medicine
title: A Prospective Controlled Study about Sleep Disorders in Drug Resistant Epilepsy
year: '2020'

---
# A Prospective Controlled Study about Sleep Disorders in Drug Resistant Epilepsy
- [PDF Link](zotero://open-pdf/library/items/NIEIEMGT)

Citation: [@bergmann2020ProspectiveControlledStudy]

***
# TL;DR (Summary)
- Median Pittsburgh Sleep Quality Index (PSQI) score was 4 in patients with drug-resistant epilepsy and 3 in controls (p = 0.024).
- Self-reported confusional arousals were more frequent in patients (30.4%) than controls (8.6%, p = 0.036).
- Probable REM sleep behavior disorder (RBD) was more common in patients (10.6%) than controls (1.4%, p = 0.030).
- A higher risk for possible sleep apnea was identified in patients (22.9%) compared to controls (5.7%, p = 0.042).
- Utilized validated questionnaires to assess sleep disorders and chronotype in patients with drug-resistant epilepsy, providing a comprehensive evaluation.
- Authors emphasize the need to investigate sleep in patients with drug-resistant epilepsy to improve quality of life and potentially seizure control.
- Suggest that future studies should use video-EEG monitoring or video-polysomnography to confirm questionnaire findings and explore the underlying mechanisms of sleep disturbances.
- Exclusion of patients with relevant comorbidities allowed for a clearer assessment of the impact of drug-resistant epilepsy on sleep.
- Despite significant differences, the overall median PSQI scores in patients were within the normal range, possibly due to the exclusion of comorbidities.

# 中文摘要 (TL;DR)
- 藥物抗性癲癇患者的匹茲堡睡眠質量指數（PSQI）中位數為4，對照組為3（p = 0.024）。
- 患者自我報告的混亂覺醒頻率（30.4%）高於對照組（8.6%，p = 0.036）。
- 患者中可能的快速眼動睡眠行為障礙（RBD）更常見（10.6%），對照組為1.4%（p = 0.030）。
- 患者中可能的睡眠呼吸暫停高風險（22.9%）高於對照組（5.7%，p = 0.042）。
- 使用經驗證的問卷來評估藥物抗性癲癇患者的睡眠障礙和晝夜節律，提供了全面的評估。
- 作者強調需要調查藥物抗性癲癇患者的睡眠，以改善生活品質並可能控制癲癇發作。
- 建議未來研究應使用視頻-腦電圖監測或視頻-多導睡眠圖來確認問卷結果，並探索睡眠障礙的潛在機制。
- 排除具有相關共病的患者，使得對藥物抗性癲癇對睡眠影響的評估更加清晰。
- 儘管存在顯著差異，但患者的整體PSQI中位數在正常範圍內，可能由於排除了共病。
